COVID-2019 Disease Coronavirus Test Kit IgM Diagnostic (Latex Assay)

Beijing Huayang Compound Medicine Technology Development Co. Ltd & GenSure Biotech Inc. professional combined and Honor produced, Buy Coronavirus Testing Kit online from manufacturer. 

HuaYangFuFang COVID-19 IgM Diagnostic Kit CDC 2019-Novel (2019-nCoV) Coronavirus testing kits | COVID-19 test kit Introduction.

Purpose & Principle

This product is used for the qualitative detection of Coronavirus COVID-19 IgM antibodies in human serum, plasma or whole blood.

This product is composed of the Coronavirus COVID-19 specific dominant epitope antigen fixed on a nitrocellulose membrane, a colored latex-labeled anti-human IgM antibody release pad and other reagents. The latex immunochromatographic technology was used to detect the Coronavirus COVID-19 antibody in human serum / plasma / whole blood using the principle of capture method.

COVID-2019 Disease Coronavirus Test Kit IgM Diagnostic (Latex Assay)

Characteristics & advantages

Use Simple and fast display test results, the fastest display results within 5 minutes; 

At present, it is the only product which is tested by latex test on the Chinese market . The raw material has higher sensitivity, stronger stability and more accurate test results;

It has passed the record keeping, sampling and registration inspection by the provincial drug administration, and has obtained the CONFORMITE EUROPEENNE (CE);

During the high incidence of the epidemic in China, it was one of the first nine "emergency examination and approval channel test products" to be approved by the "China State Council Epidemic Joint Prevention and Control Office“;

It is a state key scientific research project recommended by the Ministry of Science and Technology of the People's Republic of China of China, the Science and Technology Department of Hebei Province and the Epidemic Prevention Office of the State Council of the Science and Technology Commission of Shijiazhuang.

Buy COVID-2019 Disease Coronavirus Test Kit IgM Diagnostic (Latex Assay)

Invention& Patent

The present invention discloses a preparation method for N-S dominant epitope fusion protein of a new coronavirus, application and expression protein, microorganism, application and kit, belonging to the field of genetic engineering technology. Among them, the N-S dominant epitope fusion protein of the new coronavirus is the dominant epitope fusion protein of the new coronavirus N protein and Sprotein. Firstly, a fusion expression antigen is constructed from the S protein dominant epitope segment protein of the new coronavirus and the N protein dominant epitope segment antigen;

then, the optimized gene sequence is obtained by removing the rare codons through gene optimization, and finally obtained the high-efficiency expression, high soluble activity antigen. The N-S dominant epitope fusion protein of the new coronavirus according to the present invention is soluble expression, high yield, high purity and good activity, and is suitable for the diagnosis and detection of patients with new coronavirus.

COVID-2019 Disease Coronavirus Test Kit IgM Diagnostic (Latex Assay)

 

SARS-CoV-2 Rapid Test Kit - GenSure Biotech Inch

Company Qualification

  • Established in Dec 2016.
  • High-Tech National Enterprise
  • 23 NMPA Registered POCT products
  • 17 POCT products are expected to release by NMPA in early Apr.
  • Strong R&D Ability - One of the Comany with the strongest R&D and comprehensive products in China

Novel Coronavivus Testing Kit

  • Rapid Diagnosis - result in 5 mins only 
  • Latex stripps—the 1st one in China market, more high sensitivey 
  • Invention patent for Domestic and foreign have been in application 
  • Key Research Science Project approved by Ministry of Science and Technology, Hebei Province Science and Technology Department, and Shijiazhuang Science and Technology Commission
  • Highly recommended by Ministry of Science and Technology, Epidemic Prevention Office of the State Council, which able to get NMPA registration through green channel.

NMPA Registration Stage

  • Clinical cooperation Partner: Wuhan Tongji Hospital of Huazhong University of Science and Technology, Tianyou Hospital Affiliated to Wuhan University of Science and Technology, General Hospital of PLA (301), Shanghai CDC, Shanghai Pudong People's Hospital, Hebei CDC, Second Affiliated Hospital of Hebei Medical University
  • It has passed the Provincial Drug Administration for filing, sample sampling and registration inspection 
  • Application for clinical validation phase 
  • The clinical validation report of clinical units showed that the positive detection rate was 64.5% (40/62) and the negative detection rate was 100%. The total IgM/IgG antibody detection products detected 62 positive samples and 302 negative samples, respectively, and the results showed that the positive detection rate of reagents reached 77%.—clinical date showed in Feb 12, now our new date increase close 85%.

Export Qualification

  • CE certification is approved (NO FDA)
  • Complete export filing form, qualified for overseas sales by NMPA and China Customs
  • Registered in China Customs, with independent import and export  ability  
  • Medical Device Production and Operation License

Invention patent for preparation method and application of new crown virus N-S dominant epitope fusion protein

  • The present invention discloses a preparation method for N-S dominant epitope fusion protein of a new coronavirus, application and expression protein, microorganism, application and kit, belonging to the field of genetic engineering technology.Among them, the N-S dominant epitope fusion protein of the new coronavirus is the dominant epitope fusion protein of the new coronavirus N protein and S protein. Firstly, a fusion expression antigen is constructed from the S protein dominant epitope segment protein of the new coronavirus and the N protein dominant epitope segment antigen; then, the optimized gene sequence is obtained by removing the rare codons through gene optimization, and finally obtained the high-efficiency expression, high soluble activity antigen.The N-S dominant epitope fusion protein of the new coronavirus according to the present invention is soluble expression, high yield, high purity and good activity, and is suitable for the diagnosis and detection of patients with new coronavirus. 

Beijing Huayang Compound Medicine Technology Development Co. Ltd & GenSure Biotech Inc. professional combined and Honor produced, Buy Coronavirus Testing Kit online from manufacturer. 

Video show you how the coronavirus test kit works

Coronavirus Test Kit actual pictures: